A registry to improve hypertension management in Campania
Official title: Registro Campania Salute Network for the Treatment of Hypertension and Correlated Diseases
Run by Federico II University · NCT02211365 · Data updated 2026-11-12
This study is trying to improve how doctors manage high blood pressure by collecting and sharing patient information from general practitioners and specialists in the Campania region.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Federico II University Academic / other |
| Locations | 1 site (Naples, Napoli) |
| Status | Recruiting |
| Started | February 2014 |
| Main results expected | March 2017 |
| Study ends | April 2030 |
| Registry record updated | August 8, 2025 |
| Trial ID | NCT02211365 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are adults aged 18 and older diagnosed with hypertension.
✕Probably not a fit
Patients who refuse to sign informed consent will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Registro Campania Salute Network is a prospective registry designed to enhance the management of essential hypertension by integrating the efforts of general practitioners with hypertension specialists. This initiative involves selected general practitioners across the Campania region and the Hypertension Clinic at Federico II University in Naples, which acts as the coordinating center. Over a span of twenty years, clinical data from patient visits will be collected and analyzed to better understand the impact of hypertension and related diseases within this population.
Why it matters
Potential benefit: If successful, this registry could lead to improved management and outcomes for patients with hypertension.
How similar studies have gone: Other observational registries focusing on hypertension management have shown success in improving patient outcomes, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: -Hypertension * 18 years old Exclusion Criteria: * Refused to sign informed consent
Where it's running
-
Department od advanced biomedical sciences, Università degli studi di Napoli Federico II, Via sergio Pansini 5
Naples, Napoli, Italy Recruiting
Study contacts
- Principal investigator: Bruno Trimarco, MD — Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II
- Study coordinator: Bruno Trimarco, MD
- Email: trimarco@unina.it
- Phone: +390817462250
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.